GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0060996 | Colorectum | SER | dendritic spine development | 26/2897 | 99/18723 | 3.83e-03 | 3.17e-02 | 26 |
GO:0060491 | Colorectum | SER | regulation of cell projection assembly | 43/2897 | 188/18723 | 4.68e-03 | 3.70e-02 | 43 |
GO:00313451 | Colorectum | SER | negative regulation of cell projection organization | 42/2897 | 186/18723 | 6.51e-03 | 4.66e-02 | 42 |
GO:00508081 | Colorectum | SER | synapse organization | 85/2897 | 426/18723 | 7.17e-03 | 4.99e-02 | 85 |
GO:00726592 | Colorectum | MSS | protein localization to plasma membrane | 113/3467 | 284/18723 | 3.23e-17 | 1.55e-14 | 113 |
GO:19907782 | Colorectum | MSS | protein localization to cell periphery | 120/3467 | 333/18723 | 2.02e-14 | 5.47e-12 | 120 |
GO:00329702 | Colorectum | MSS | regulation of actin filament-based process | 128/3467 | 397/18723 | 2.47e-11 | 3.49e-09 | 128 |
GO:19054752 | Colorectum | MSS | regulation of protein localization to membrane | 68/3467 | 175/18723 | 2.16e-10 | 2.09e-08 | 68 |
GO:00901502 | Colorectum | MSS | establishment of protein localization to membrane | 90/3467 | 260/18723 | 4.11e-10 | 3.49e-08 | 90 |
GO:00329562 | Colorectum | MSS | regulation of actin cytoskeleton organization | 113/3467 | 358/18723 | 1.46e-09 | 1.07e-07 | 113 |
GO:19030762 | Colorectum | MSS | regulation of protein localization to plasma membrane | 45/3467 | 104/18723 | 4.82e-09 | 3.17e-07 | 45 |
GO:19043752 | Colorectum | MSS | regulation of protein localization to cell periphery | 51/3467 | 125/18723 | 5.46e-09 | 3.55e-07 | 51 |
GO:00988762 | Colorectum | MSS | vesicle-mediated transport to the plasma membrane | 54/3467 | 136/18723 | 6.20e-09 | 3.95e-07 | 54 |
GO:00161972 | Colorectum | MSS | endosomal transport | 79/3467 | 230/18723 | 7.04e-09 | 4.39e-07 | 79 |
GO:00331572 | Colorectum | MSS | regulation of intracellular protein transport | 76/3467 | 229/18723 | 7.03e-08 | 3.56e-06 | 76 |
GO:00323862 | Colorectum | MSS | regulation of intracellular transport | 102/3467 | 337/18723 | 9.73e-08 | 4.71e-06 | 102 |
GO:00619512 | Colorectum | MSS | establishment of protein localization to plasma membrane | 28/3467 | 60/18723 | 5.80e-07 | 2.21e-05 | 28 |
GO:00430872 | Colorectum | MSS | regulation of GTPase activity | 101/3467 | 348/18723 | 1.00e-06 | 3.46e-05 | 101 |
GO:01060272 | Colorectum | MSS | neuron projection organization | 34/3467 | 93/18723 | 3.04e-05 | 6.14e-04 | 34 |
GO:00109752 | Colorectum | MSS | regulation of neuron projection development | 115/3467 | 445/18723 | 6.91e-05 | 1.20e-03 | 115 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ARHGAP44 | SNV | Missense_Mutation | novel | c.569N>G | p.Val190Gly | p.V190G | Q17R89 | protein_coding | deleterious(0) | probably_damaging(0.93) | TCGA-A2-A4RW-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
ARHGAP44 | SNV | Missense_Mutation | novel | c.1462G>C | p.Ala488Pro | p.A488P | Q17R89 | protein_coding | deleterious(0.01) | benign(0.303) | TCGA-E2-A15M-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD |
ARHGAP44 | insertion | Nonsense_Mutation | novel | c.2407_2408insACTCAGAGACGTCCAGACACTGAGCTGT | p.Val803AspfsTer8 | p.V803Dfs*8 | Q17R89 | protein_coding | | | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ARHGAP44 | insertion | In_Frame_Ins | novel | c.197_198insTCTCACTCATAGGTGGGAATTGAACAATGAGAA | p.Ser66_Lys67insLeuThrHisArgTrpGluLeuAsnAsnGluAsn | p.S66_K67insLTHRWELNNEN | Q17R89 | protein_coding | | | TCGA-E9-A1NI-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | CR |
ARHGAP44 | deletion | Frame_Shift_Del | novel | c.234delG | p.Met79TrpfsTer17 | p.M79Wfs*17 | Q17R89 | protein_coding | | | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD |
ARHGAP44 | SNV | Missense_Mutation | rs768572384 | c.2105N>T | p.Ser702Leu | p.S702L | Q17R89 | protein_coding | deleterious_low_confidence(0.01) | benign(0.079) | TCGA-C5-A2LV-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
ARHGAP44 | SNV | Missense_Mutation | novel | c.155N>T | p.Ala52Val | p.A52V | Q17R89 | protein_coding | deleterious(0.01) | possibly_damaging(0.475) | TCGA-C5-A8XH-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
ARHGAP44 | SNV | Missense_Mutation | | c.2332N>C | p.Asp778His | p.D778H | Q17R89 | protein_coding | deleterious_low_confidence(0) | benign(0.401) | TCGA-DR-A0ZM-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unspecific | Cisplatin | SD |
ARHGAP44 | SNV | Missense_Mutation | | c.598G>A | p.Asp200Asn | p.D200N | Q17R89 | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-MU-A51Y-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
ARHGAP44 | SNV | Missense_Mutation | novel | c.1205N>C | p.Met402Thr | p.M402T | Q17R89 | protein_coding | deleterious(0) | benign(0.207) | TCGA-VS-A9UB-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |